- Lehn N, Schaller E, Wagner H, et al. Frequency of toxic shock syndrome toxin- and enterotoxin-
producing clinical isolates ofStaphylococcus aureus. Eur J Clin Microbiol Infect Dis 1995; 14(1):43–46. - Barrett JA, Graham DR. Toxic shock syndrome presenting as encephalopathy. J Infect 1986; 12(3):
276–278. - Chesney RW, Chesney PJ, Davis JP, et al. Renal manifestations of the staphylococcal toxic-shock
syndrome. Am J Med 1981; 71(4):583–588. - Herzer CM. Toxic shock syndrome: broadening the differential diagnosis. J Am Board Fam Pract
2001; 14(2):131–136. - McKenna UG, Meadows JA III, Brewer NS, et al. Toxic shock syndrome, a newly recognized disease
entity. Report of 11 cases. Mayo Clin Proc 1980; 55(11):663–672. - Chesney PJ, Davis JP, Purdy WK, et al. Clinical manifestations of toxic shock syndrome. JAMA 1981;
246(7):741–748. - Andrews MM, Parent EM, Barry M, et al. Recurrent nonmenstrual toxic shock syndrome: clinical
manifestations, diagnosis, and treatment. Clin Infect Dis 2001; 32(10):1470–1479. - Reingold AL, Dan BB, Shands KN, et al. Toxic-shock syndrome not associated with menstruation. A
review of 54 cases. Lancet 1982; 1(8262):1–4. - Reingold AL, Hargrett NT, Dan BB, et al. Nonmenstrual toxic shock syndrome: a review of 130 cases.
Ann Int Med 1982; 96(6 pt 2):871–874. - Defining the group A streptococcal toxic shock syndrome. Rationale and consensus definition. The
Working Group on Severe Streptococcal Infections. JAMA 1993; 269(3):390–391. - Manders SM. Toxin-mediated streptococcal and staphylococcal disease. J Am Acad Dermatol 1998;
39(3):383–398. - Ladhani S. Recent developments in staphylococcal scalded skin syndrome. Clin Microbiol Infect
2001; 7(6):301–307. - Adesiyun AA, Lenz W, Schaal KP. Exfoliative toxin production byStaphylococcus aureusstrains
isolated from animals and human beings in Nigeria. Microbiologica 1991; 14(4):357–362. - Dancer SJ, Noble WC. Nasal, axillary, and perineal carriage ofStaphylococcus aureusamong women:
identification of strains producing epidermolytic toxin. J Clin Pathol 1991; 44(8):681–684. - Ladhani S, Poston SM, Joannou CL, et al. Staphylococcal scalded skin syndrome: exfoliative toxin A
(ETA) induces serine protease activity when combined with A431 cells. Acta Paediatr 1999; 88(7):
776–779. - Papageorgiou AC, Plano LR, Collins CM, et al. Structural similarities and differences in
Staphylococcus aureusexfoliative toxins A and B as revealed by their crystal structures. Protein Sci
2000; 9(3):610–618. - Prevost G, Couppie P, Monteil H. Staphylococcal epidermolysins. Curr Opin Infect Dis 2003; 16(2):
71–76. - Lyell A. Toxic epidermal necrolysis (the scalded skin syndrome): a reappraisal. Br J Dermatol 1979;
100(1):69–86. - Melish ME. Staphylococci, streptococci and the skin: review of impetigo and staphylococcal scalded
skin syndrome. Semin Dermatol 1982; 1:101–109. - Beers B, Wilson B. Adult staphylococcal scalded skin syndrome. Int J Dermatol 1990; 29(6):428–429.
- Moss C, Gupta E. The Nikolsky sign in staphylococcal scalded skin syndrome. Arch Dis Child 1998;
79(3):290. - Gemmell CG. Staphylococcal scalded skin syndrome. J Med Microbiol 1995; 43(5):318–327.
- Cribier B, Piemont Y, Grosshans E. Staphylococcal scalded skin syndrome in adults. A clinical
review illustrated with a new case. J Am Acad Dermatol 1994; 30(2 pt 2):319–324. - Goldberg NS, Ahmed T, Robinson B, et al. Staphylococcal scalded skin syndrome mimicking acute
graft-vs.-host disease in a bone marrow transplant recipient. Arch Dermatol 1989; 125(1):85–87. - Ladhani S, Robbie S, Garratt RC, et al. Development and evaluation of detection systems for
staphylococcal exfoliative toxin A responsible for scalded-skin syndrome. J Clin Microbiol 2001;
39(6):2050–2054. - Gentilhomme E, Faure M, Piemont Y, et al. Action of staphylococcal exfoliative toxins on epidermal
cell cultures and organotypic skin. J Dermatol 1990; 17(9):526–532. - Leyden JJ, Gately LE III. Staphylococcal and streptococcal infections. In: Sanders CV, Nesbitt LTJ,
eds. The Skin and Infection: A color Atlas and Text. Baltimore: Williams and Wilkins, 1995:27–38. - Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific
desquamation of the fingers and toes in children. Arerugi 1967; 16(3):178–222. - Burns JC, Glode MP. Kawasaki syndrome. Lancet 2004; 364(9433):533–544.
- Royle J, Burgner D, Curtis N. The diagnosis and management of Kawasaki disease. J Paediatr Child
Health 2005; 41(3):87–93.
Fever and Rash in Critical Care 45